AChE-IN-19 is used in the research of Alzheimer's disease due to its potent acetylcholinesterase (AChE) inhibitory activity (IC50 = 0.56 μM), its ability to inhibit Aβ aggregation, and its neuroprotective effects with minimal toxicity toward SH-SY5Y cells.